— Know what they know.
Not Investment Advice

LIVN NASDAQ

LivaNova PLC
1W: -2.0% 1M: -8.9% 3M: -10.7% YTD: +23.8% 1Y: +48.3% 3Y: +41.2% 5Y: -8.0%
$75.07
+0.37 (+0.50%)
 
Weekly Expected Move ±3.1%
$70 $73 $75 $77 $80
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 42 · $4.1B mcap · 55M float · 1.27% daily turnover · Short 52% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
55.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 30.2%  ·  5Y Avg: 0.1%
Cost Advantage ★
71
Intangibles
55
Switching Cost
47
Network Effect
62
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LIVN has a Narrow competitive edge (55.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Cost Advantage. ROIC of 30.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$85
Low
$89
Avg Target
$93
High
Based on 3 analysts since Aug 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$90.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-02 Piper Sandler — $85 $90 +5 +12.3% $80.16
2026-08-05 Stifel Nicolaus — $80 $85 +5 +11.0% $76.58
2026-08-05 Needham — $81 $93 +12 +21.4% $76.58
2026-07-15 Mizuho Securities — $90 $95 +5 +20.1% $79.12
2026-06-22 KeyBanc — $81 $92 +11 +17.2% $78.50
2026-05-07 Mizuho Securities — $72 $90 +18 +35.8% $66.26
2026-05-07 Barclays — $67 $76 +9 +14.7% $66.26
2026-02-25 Stifel Nicolaus — $72 $80 +8 +13.8% $70.29
2026-02-25 Needham Mike Matson $88 $81 -7 +15.2% $70.29
2026-02-19 Piper Sandler Adam Maeder Initiated $85 — +26.2% $67.33
2026-01-09 Barclays — $56 $67 +11 +3.2% $64.95
2026-01-09 Goldman Sachs David Roman $55 $66 +11 +1.6% $64.95
2025-12-18 KeyBanc Brett Fishbin Initiated $81 — +30.5% $62.08
2025-12-17 Mizuho Securities Anthony Petrone $70 $72 +2 +14.1% $63.08
2025-12-16 Robert W. Baird — $66 $75 +9 +19.0% $63.05
2025-10-01 Goldman Sachs — $65 $55 -10 +5.0% $52.38
2025-03-07 Barclays — $62 $56 -6 +43.0% $39.17
2024-10-31 Mizuho Securities Anthony Petrone Initiated $70 — +37.1% $51.05
2024-10-04 Goldman Sachs David Roman $63 $65 +2 +20.6% $53.90
2024-09-17 Robert W. Baird David Rescott Initiated $66 — +35.3% $48.79
2024-07-25 Stifel Nicolaus Rick Wise $70 $72 +2 +34.7% $53.45
2024-06-06 Stifel Nicolaus Rick Wise $65 $70 +5 +31.7% $53.16
2024-03-20 Stifel Nicolaus Rick Wise Initiated $65 — +14.8% $56.63
2022-12-21 Barclays — Initiated $62 — +10.6% $56.05
2022-11-23 Goldman Sachs — $73 $63 -10 +16.8% $53.95
2022-08-16 Goldman Sachs — Initiated $73 — +14.3% $63.86
2022-08-04 Needham — Initiated $88 — +39.9% $62.89

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
4
ROE
4
ROA
5
D/E
1
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LIVN receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-05 B B+
2026-07-27 B+ B
2026-07-02 B B+
2026-05-18 B+ B
2026-05-06 C+ B+
2026-05-04 C C+
2026-03-02 C+ C
2026-02-26 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 63 Grade A+
Profitability
67
Balance Sheet
74
Earnings Quality
77
Growth
67
Value
43
Momentum
92
Safety
50
Cash Flow
52
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LIVN scores highest in Momentum (92/100) and lowest in Value (43/100). An overall grade of A+ places LIVN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.47
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.51
Unlikely Manipulator
Ohlson O-Score
-8.30
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 64.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.32x
Accruals: -2.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LIVN scores 2.47, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LIVN scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LIVN's score of -2.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LIVN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LIVN receives an estimated rating of BBB+ (score: 64.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LIVN's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.76x
PEG
0.08x
P/S
2.80x
P/B
3.12x
P/FCF
31.21x
P/OCF
18.57x
EV/EBITDA
24.71x
EV/Revenue
3.03x
EV/EBIT
29.22x
EV/FCF
30.10x
Earnings Yield
4.07%
FCF Yield
3.20%
Shareholder Yield
0.01%
Graham Number
$42.12
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.8x earnings, LIVN commands a growth premium. Graham's intrinsic value formula yields $42.12 per share, 78% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.768
NI / EBT
×
Interest Burden
0.698
EBT / EBIT
×
EBIT Margin
0.104
EBIT / Rev
×
Asset Turnover
0.572
Rev / Assets
×
Equity Multiplier
2.103
Assets / Equity
=
ROE
15.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LIVN's ROE of 15.4% is driven by Asset Turnover (0.572), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.77 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$28.47
Price/Value
2.89x
Margin of Safety
-188.82%
Premium
188.82%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LIVN's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. LIVN trades at a 189% premium to its adjusted intrinsic value of $28.47, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 21.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$75.07
Median 1Y
$68.39
5th Pctile
$34.14
95th Pctile
$136.28
Ann. Volatility
42.5%
Analyst Target
$90.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Damien McDonald,
Former CEO
$286,826 $4,746,297 $8,210,340
Marco Dolci, President,
sident, Cardiopulmonary BU
$571,833 $2,094,554 $4,802,288
William Kozy, Interim
Interim CEO
$697,500 $1,249,961 $3,060,725
Alex Shvartsburg,
CFO
$536,885 $1,168,289 $2,771,180
Michael Hutchinson, President,
e President, Chief Legal Officer and Company Secretary
$505,077 $730,181 $2,072,351
Trui Hebbelinck, CHRO
$396,347 $657,120 $1,777,160

CEO Pay Ratio

49:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $8,210,340
Avg Employee Cost (SGA/emp): $166,303
Employees: 3,300

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,300
+13.8% YoY
Revenue / Employee
$420,636
Rev: $1,388,100,000
Profit / Employee
$-73,485
NI: $-242,500,000
SGA / Employee
$166,303
Avg labor cost proxy
R&D / Employee
$56,303
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -31.1% -11.6% -8.9% -2.8% -7.8% -6.9% -6.5% -7.7% 0.2% 1.4% -2.6% -1.3% 1.9% 4.9% -19.7% -17.9% -17.6% -19.2% 9.5% 15.4% 15.41%
ROA -17.5% -6.1% -4.4% -1.4% -4.4% -3.8% -3.5% -4.2% 0.1% 0.7% -1.3% -0.7% 1.0% 2.6% -8.9% -8.5% -8.6% -9.5% 4.2% 7.3% 7.33%
ROIC -15.4% -0.3% 0.6% 4.5% -4.5% -3.9% -5.4% -6.1% 0.3% -3.3% -2.5% -1.3% 0.2% 5.9% 13.1% 13.7% 15.3% 15.2% 17.8% 30.2% 30.21%
ROCE -7.8% -4.2% -2.5% 0.8% -2.4% -1.3% -0.9% -1.5% 3.7% -1.1% -3.0% -2.2% 0.0% 7.2% -7.2% -7.3% -8.0% -9.0% 9.8% 7.9% 7.90%
Gross Margin 66.6% 73.1% 70.1% 72.5% 67.7% 66.8% 66.1% 69.8% 70.5% 61.3% 70.3% 67.4% 70.8% 68.2% 69.7% 67.8% 68.4% 66.4% 67.6% 70.1% 70.07%
Operating Margin 6.5% 7.6% 4.0% 12.5% -52.2% 5.1% -0.9% 5.9% 1.6% -28.4% 5.5% 12.6% 11.2% 11.5% 15.3% 15.4% 15.1% 11.8% 14.4% 12.7% 12.67%
Net Margin -17.2% -3.2% 1.2% 6.5% -42.5% 0.6% 2.8% 0.4% -2.6% 5.3% -14.2% 5.1% 10.4% 17.4% -1.0% 7.7% 7.5% 8.6% 6.2% 27.8% 27.80%
EBITDA Margin -5.6% 6.4% 11.7% 18.7% -31.6% 12.7% 14.5% 11.9% 9.8% -20.2% -1.8% 15.5% 23.1% 26.4% -90.2% 17.2% 15.9% 13.2% 13.9% 6.6% 6.58%
FCF Margin 7.8% 7.4% 8.4% 5.0% 5.9% 4.2% 3.4% 2.6% 0.8% 3.5% 2.6% 7.0% 8.8% 10.8% 11.4% 12.4% 14.2% 12.5% 11.2% 10.1% 10.08%
OCF Margin 10.2% 9.9% 10.6% 7.2% 8.3% 6.8% 6.2% 5.3% 3.5% 6.5% 5.4% 10.4% 12.7% 14.6% 15.4% 16.5% 18.6% 18.3% 17.1% 16.9% 16.94%
ROE 3Y Avg snapshot only -1.98%
ROE 5Y Avg snapshot only -3.26%
ROA 3Y Avg snapshot only -0.66%
ROIC 3Y Avg snapshot only -2.04%
ROIC Economic snapshot only 21.28%
Cash ROA snapshot only 9.44%
Cash ROIC snapshot only 21.48%
CROIC snapshot only 12.78%
NOPAT Margin snapshot only 23.83%
Pretax Margin snapshot only 7.25%
R&D / Revenue snapshot only 13.83%
SGA / Revenue snapshot only 39.66%
SBC / Revenue snapshot only 2.35%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -9.86 -33.46 -42.02 -103.76 -28.17 -34.65 -28.69 -28.58 995.65 160.12 -95.09 -180.40 121.10 40.06 -9.62 -11.66 -13.30 -13.83 33.16 24.55 21.759
P/S Ratio 3.95 4.50 4.31 3.32 2.67 2.92 2.25 2.56 2.55 2.44 2.55 2.47 2.31 2.02 1.68 1.88 2.14 2.42 2.48 3.15 2.802
P/B Ratio 3.11 3.60 3.43 2.64 2.37 2.47 1.91 2.24 2.33 2.20 2.47 2.41 2.19 1.92 2.07 2.19 2.50 2.79 2.93 3.49 3.115
P/FCF 50.30 60.76 51.53 66.51 45.50 68.84 65.49 96.98 337.57 70.36 99.24 35.11 26.39 18.64 14.69 15.19 15.10 19.35 22.06 31.21 31.209
P/OCF 38.65 45.61 40.86 46.29 32.09 42.73 36.22 48.64 72.12 37.53 47.14 23.86 18.12 13.84 10.85 11.37 11.54 13.18 14.47 18.57 18.573
EV/EBITDA -69.91 -7884.74 384.96 44.12 209.80 108.54 58.84 101.16 23.81 82.72 -699.63 350.13 58.32 13.73 -26.63 -35.23 -32.83 -26.47 15.52 24.71 24.707
EV/Revenue 4.05 4.58 4.37 3.42 2.74 3.28 2.30 2.64 2.90 2.76 2.86 2.76 2.58 2.22 1.63 1.80 2.03 2.30 2.34 3.03 3.034
EV/EBIT -34.64 -74.98 -84.95 210.73 -59.70 -124.73 -140.81 -94.32 42.63 -142.29 -53.04 -71.31 6989.79 18.37 -15.90 -19.25 -19.83 -19.63 19.38 29.22 29.215
EV/FCF 51.62 61.79 52.22 68.50 46.70 77.28 67.11 100.11 383.32 79.73 111.31 39.19 29.46 20.46 14.27 14.51 14.27 18.41 20.78 30.10 30.099
Earnings Yield -10.1% -3.0% -2.4% -1.0% -3.5% -2.9% -3.5% -3.5% 0.1% 0.6% -1.1% -0.6% 0.8% 2.5% -10.4% -8.6% -7.5% -7.2% 3.0% 4.1% 4.07%
FCF Yield 2.0% 1.6% 1.9% 1.5% 2.2% 1.5% 1.5% 1.0% 0.3% 1.4% 1.0% 2.8% 3.8% 5.4% 6.8% 6.6% 6.6% 5.2% 4.5% 3.2% 3.20%
PEG Ratio snapshot only 0.082
Price/Tangible Book snapshot only 14.064
EV/OCF snapshot only 17.912
EV/Gross Profit snapshot only 4.451
Acquirers Multiple snapshot only 22.515
Shareholder Yield snapshot only 0.01%
Graham Number snapshot only $42.12
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.98 0.97 2.63 2.93 2.96 2.98 2.86 3.27 3.23 2.95 3.17 3.45 3.37 2.87 1.58 1.29 1.33 1.36 1.33 1.45 1.450
Quick Ratio 0.79 0.82 2.26 2.47 2.53 2.54 2.41 2.73 2.68 2.51 2.71 2.94 2.87 2.50 1.37 1.09 1.12 1.16 1.11 1.21 1.206
Debt/Equity 0.22 0.22 0.39 0.40 0.50 0.48 0.47 0.50 0.51 0.50 0.55 0.55 0.52 0.51 0.66 0.43 0.42 0.39 0.28 0.27 0.266
Net Debt/Equity 0.08 0.06 0.05 0.08 0.06 0.30 0.05 0.07 0.32 0.29 0.30 0.28 0.25 0.19 -0.06 -0.10 -0.14 -0.14 -0.17 -0.12 -0.124
Debt/Assets 0.13 0.13 0.21 0.22 0.26 0.25 0.25 0.27 0.27 0.26 0.28 0.28 0.27 0.27 0.26 0.19 0.19 0.18 0.13 0.13 0.133
Debt/EBITDA -4.82 -477.04 43.04 6.44 43.46 18.78 14.21 22.02 4.56 16.64 -139.74 71.00 12.38 3.34 -8.69 -7.23 -5.85 -3.93 1.55 1.95 1.948
Net Debt/EBITDA -1.78 -130.97 5.14 1.28 5.38 11.85 1.43 3.17 2.84 9.72 -75.90 36.50 6.07 1.22 0.78 1.66 1.92 1.35 -0.95 -0.91 -0.911
Interest Coverage -2.02 -1.26 -1.26 0.41 -1.13 -0.56 -0.32 -0.56 1.34 -0.38 -1.04 -0.76 0.01 2.40 -2.09 -2.06 -2.54 -2.79 3.37 3.31 3.312
Equity Multiplier 1.68 1.70 1.87 1.82 1.93 1.90 1.87 1.89 1.90 1.90 2.01 1.97 1.93 1.90 2.47 2.23 2.21 2.17 2.08 1.99 1.993
Cash Ratio snapshot only 0.731
Debt Service Coverage snapshot only 3.917
Cash to Debt snapshot only 1.468
FCF to Debt snapshot only 0.421
Defensive Interval snapshot only 358.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.44 0.45 0.43 0.43 0.46 0.45 0.44 0.46 0.49 0.49 0.50 0.50 0.51 0.51 0.51 0.53 0.53 0.54 0.56 0.57 0.572
Inventory Turnover 2.51 3.02 2.68 2.42 2.41 2.67 2.58 2.55 2.49 2.76 2.57 2.54 2.50 2.62 2.57 2.53 2.58 2.84 2.91 2.77 2.771
Receivables Turnover 5.54 5.60 5.67 5.67 5.74 5.55 5.80 5.98 6.18 5.79 6.11 6.26 6.42 6.14 6.20 6.22 6.60 6.78 6.65 6.52 6.518
Payables Turnover 5.75 4.71 4.71 4.40 4.55 4.42 4.44 4.60 5.34 4.93 5.02 4.96 5.74 5.13 4.83 4.81 5.12 5.31 4.98 4.92 4.921
DSO 66 65 64 64 64 66 63 61 59 63 60 58 57 59 59 59 55 54 55 56 56.0 days
DIO 145 121 136 151 152 136 141 143 146 132 142 144 146 139 142 144 142 128 125 132 131.7 days
DPO 63 78 78 83 80 83 82 79 68 74 73 74 64 71 76 76 71 69 73 74 74.2 days
Cash Conversion Cycle 148 109 123 132 135 120 122 125 137 121 129 128 140 128 125 127 126 114 107 114 113.5 days
Fixed Asset Turnover snapshot only 4.458
Operating Cycle snapshot only 187.7 days
Cash Velocity snapshot only 2.848
Capital Intensity snapshot only 1.795
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 8.7% 10.8% 9.4% -0.4% -1.7% -1.3% 1.7% 6.6% 10.0% 12.9% 13.4% 11.5% 11.0% 8.7% 7.6% 8.2% 8.6% 10.7% 12.4% 12.4% 12.39%
Net Income -98.8% 60.1% 74.7% 91.6% 76.7% 38.1% 22.4% -2.0% 1.0% 1.2% 61.2% 82.9% 7.3% 2.6% -6.0% -11.7% -10.2% -4.8% 1.5% 1.9% 1.89%
EPS -87.5% 63.6% 77.2% 92.4% 77.6% 38.6% 22.0% -2.0% 1.0% 1.2% 61.3% 83.1% 7.2% 2.6% -5.9% -11.7% -10.1% -4.8% 1.5% 1.9% 1.87%
FCF 1.5% 1.7% 6.5% -13.4% -26.4% -43.4% -58.3% -43.6% -85.8% -8.0% -15.1% 2.0% 11.8% 2.4% 3.8% 90.2% 76.2% 27.5% 10.7% -8.5% -8.49%
EBITDA 31.3% 88.0% 3.3% 3.8% 1.2% 52.4% 2.5% -64.1% 9.2% 24.5% -1.1% -66.3% -59.7% 4.3% -15.1% -8.0% -2.5% -1.6% 3.8% 3.7% 3.71%
Op. Income -98.9% 98.0% 1.0% 1.3% 74.7% -14.6% -9.6% -2.3% 1.5% 10.8% 43.7% 73.7% -87.9% 2.9% 4.2% 7.5% 47.0% 54.5% 25.7% 13.0% 13.03%
OCF Growth snapshot only 15.09%
Asset Growth snapshot only 5.35%
Equity Growth snapshot only 18.03%
Debt Growth snapshot only -27.10%
Shares Change snapshot only 2.91%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -1.7% -2.2% -2.5% -2.5% -2.4% -2.0% -1.0% 3.4% 5.5% 7.3% 8.0% 5.8% 6.3% 6.6% 7.5% 8.8% 9.9% 10.8% 11.1% 10.7% 10.70%
Revenue 5Y 2.8% -3.1% -3.2% -3.4% -3.7% -3.1% -2.1% -0.7% 0.5% 0.8% 1.4% 2.0% 2.6% 2.9% 3.5% 5.9% 7.2% 8.2% 8.8% 7.6% 7.57%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — 74.0% 85.4% 85.43%
EBITDA 5Y — — -41.2% -13.3% -39.0% -30.3% -25.4% -29.5% 2.9% — — — — — — — — — — — —
Gross Profit 3Y -2.3% -1.5% -1.3% -0.9% -1.0% -1.7% -1.8% 3.0% 6.4% 9.9% 11.9% 8.9% 8.5% 7.3% 7.6% 7.9% 8.6% 10.1% 10.8% 11.0% 10.99%
Gross Profit 5Y 3.9% -0.1% -0.6% -0.8% -1.0% -1.6% -0.9% 0.2% 1.7% 1.0% 1.8% 2.0% 2.4% 3.1% 3.2% 6.2% 7.8% 10.2% 11.0% 9.8% 9.76%
Op. Income 3Y — — — — — — — — — — — — — — 1.5% 30.8% — — — — —
Op. Income 5Y — — — — — — — — -6.4% — — — — — — — — — — — —
FCF 3Y -0.4% -2.4% 10.3% 41.4% — — — — — — 38.5% 13.2% 10.2% 21.0% 19.1% 47.2% 47.4% 58.7% 65.0% 73.0% 73.02%
FCF 5Y 31.4% 8.1% 2.3% -6.9% -5.9% -5.4% -4.9% -17.7% -36.5% -13.5% -13.8% 36.5% — — — — — — 69.7% 20.4% 20.38%
OCF 3Y -3.4% -5.4% 2.1% 10.2% — — — — — — 11.6% 11.5% 14.4% 21.5% 22.0% 43.7% 43.6% 53.8% 55.9% 63.4% 63.43%
OCF 5Y 16.4% 2.5% -0.9% -7.7% -5.8% -5.2% -3.8% -12.0% -19.5% -9.1% -8.9% 18.1% — — — — — — 39.7% 22.5% 22.50%
Assets 3Y -5.5% -4.8% -2.4% -3.8% -4.1% -1.6% -2.2% -2.2% -2.6% 0.4% 1.3% 0.8% 4.6% 4.4% 1.9% 2.4% 4.9% 4.3% 3.1% 4.1% 4.09%
Assets 5Y -2.5% -1.2% 0.4% -1.6% -3.2% -1.7% -3.2% -2.1% -2.3% -1.0% -1.1% -1.3% 0.1% 0.8% 0.8% 0.0% 0.3% 1.7% 1.2% 2.0% 1.96%
Equity 3Y -9.7% -4.9% -4.6% -4.7% -8.5% -4.4% -4.1% -2.4% -3.2% 4.8% 4.7% 6.1% -0.1% 0.7% -7.1% -4.3% 0.3% -0.2% -0.4% 2.2% 2.23%
Book Value 3Y -11.5% -7.8% -8.2% -8.3% -11.2% -7.7% -7.3% -5.7% -6.5% 1.0% 1.1% 2.3% -1.9% -0.2% -7.3% -4.7% -0.7% -0.6% -1.6% 0.8% 0.81%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.14 0.72 0.76 0.74 0.65 0.53 0.40 0.08 0.02 0.04 0.09 0.21 0.32 0.43 0.55 0.88 0.93 0.95 0.96 0.92 0.916
Earnings Stability 0.83 0.39 0.29 0.17 0.33 0.03 0.01 0.01 0.06 0.41 0.25 0.44 0.50 0.67 0.05 0.10 0.20 0.18 0.48 0.44 0.442
Margin Stability 0.95 0.93 0.93 0.94 0.95 0.95 0.94 0.95 0.95 0.96 0.95 0.95 0.96 0.99 0.99 0.98 0.98 0.96 0.95 0.96 0.956
Rev. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.85 0.91 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — 0.00 0.00 — — — — — — —
ROE Trend -0.16 0.11 0.15 0.22 0.15 0.14 0.17 0.12 0.20 0.10 0.05 0.04 0.06 0.08 -0.17 -0.14 -0.20 -0.23 0.21 0.24 0.243
Gross Margin Trend -0.04 0.02 0.03 0.06 0.06 0.04 0.03 0.01 0.01 -0.02 -0.01 -0.02 -0.02 0.01 0.01 0.02 0.01 0.00 -0.01 -0.00 -0.000
FCF Margin Trend 0.21 0.19 0.18 0.14 0.10 0.07 -0.01 -0.03 -0.06 -0.02 -0.03 0.03 0.05 0.07 0.08 0.08 0.09 0.05 0.04 0.00 0.004
Sustainable Growth Rate — — — — — — — — 0.2% 1.4% — — 1.9% 4.9% — — — — 9.5% 15.4% 15.41%
Internal Growth Rate — — — — — — — — 0.1% 0.7% — — 1.0% 2.6% — — — — 4.4% 7.9% 7.91%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.26 -0.73 -1.03 -2.24 -0.88 -0.81 -0.79 -0.59 13.81 4.27 -2.02 -7.56 6.68 2.89 -0.89 -1.02 -1.15 -1.05 2.29 1.32 1.322
FCF/OCF 0.77 0.75 0.79 0.70 0.71 0.62 0.55 0.50 0.21 0.53 0.48 0.68 0.69 0.74 0.74 0.75 0.76 0.68 0.66 0.60 0.595
FCF/Net Income snapshot only 0.787
OCF/EBITDA snapshot only 1.379
CapEx/Revenue 2.4% 2.5% 2.2% 2.2% 2.5% 2.6% 2.8% 2.6% 2.8% 3.0% 2.8% 3.3% 4.0% 3.8% 4.0% 4.2% 4.4% 5.8% 5.9% 6.9% 6.86%
CapEx/Depreciation snapshot only 3.619
Accruals Ratio -0.22 -0.10 -0.09 -0.04 -0.08 -0.07 -0.06 -0.07 -0.02 -0.02 -0.04 -0.06 -0.06 -0.05 -0.17 -0.17 -0.18 -0.19 -0.05 -0.02 -0.024
Sloan Accruals snapshot only 0.020
Cash Flow Adequacy snapshot only 2.470
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — 0.0% 0.0% — — 0.0% 0.0% — — — — 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — 2.5% 39.9% — — 34.1% 13.3% — — — — 4.1% 0.3% 0.29%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.3% 0.3% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.0% 0.01%
Net Buyback Yield 0.3% 0.3% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.0% 0.01%
Total Shareholder Return 0.3% 0.3% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.0% 0.01%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.07 1.08 1.11 1.38 1.10 1.15 1.15 1.15 0.15 -0.22 0.25 0.15 -0.38 0.72 1.15 1.16 1.13 1.10 0.88 1.77 1.768
Interest Burden (EBT/EBIT) 3.20 2.04 1.80 -1.43 1.88 2.80 4.15 2.79 0.25 3.63 1.96 2.33 -136.37 0.58 1.48 1.48 1.39 1.36 0.70 0.70 0.698
EBIT Margin -0.12 -0.06 -0.05 0.02 -0.05 -0.03 -0.02 -0.03 0.07 -0.02 -0.05 -0.04 0.00 0.12 -0.10 -0.09 -0.10 -0.12 0.12 0.10 0.104
Asset Turnover 0.44 0.45 0.43 0.43 0.46 0.45 0.44 0.46 0.49 0.49 0.50 0.50 0.51 0.51 0.51 0.53 0.53 0.54 0.56 0.57 0.572
Equity Multiplier 1.77 1.91 2.03 2.04 1.80 1.80 1.87 1.85 1.91 1.90 1.94 1.93 1.91 1.90 2.22 2.10 2.06 2.03 2.26 2.10 2.103
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-8.03 $-2.61 $-1.95 $-0.60 $-1.80 $-1.60 $-1.52 $-1.80 $0.05 $0.32 $-0.59 $-0.30 $0.43 $1.16 $-4.08 $-3.86 $-3.94 $-4.45 $1.92 $3.35 $3.35
Book Value/Share $25.44 $24.29 $23.85 $23.70 $21.42 $22.45 $22.77 $22.97 $22.69 $23.53 $22.62 $22.76 $24.00 $24.14 $19.01 $20.52 $20.96 $22.02 $21.67 $23.54 $24.10
Tangible Book/Share $-0.03 $-0.09 $0.09 $-0.10 $0.74 $1.31 $1.65 $1.93 $2.05 $4.30 $3.63 $4.18 $5.13 $6.09 $0.66 $1.65 $2.39 $3.25 $3.60 $5.85 $5.85
Revenue/Share $20.06 $19.43 $18.97 $18.81 $19.00 $18.99 $19.39 $20.09 $20.71 $21.24 $21.95 $22.16 $22.75 $22.91 $23.44 $23.93 $24.44 $25.47 $25.64 $26.14 $26.75
FCF/Share $1.57 $1.44 $1.59 $0.94 $1.12 $0.81 $0.67 $0.53 $0.16 $0.74 $0.56 $1.56 $1.99 $2.49 $2.67 $2.96 $3.47 $3.18 $2.88 $2.63 $2.70
OCF/Share $2.05 $1.92 $2.00 $1.35 $1.58 $1.30 $1.20 $1.06 $0.73 $1.38 $1.19 $2.30 $2.90 $3.35 $3.62 $3.96 $4.54 $4.67 $4.39 $4.43 $4.53
Cash/Share $3.53 $3.90 $8.17 $7.52 $9.46 $3.98 $9.70 $9.90 $4.33 $4.91 $5.73 $6.03 $6.35 $7.84 $13.57 $10.85 $11.70 $11.66 $9.65 $9.18 $9.39
EBITDA/Share $-1.16 $-0.01 $0.22 $1.46 $0.25 $0.57 $0.76 $0.52 $2.52 $0.71 $-0.09 $0.17 $1.01 $3.70 $-1.43 $-1.22 $-1.51 $-2.21 $3.86 $3.21 $3.21
Debt/Share $5.60 $5.38 $9.27 $9.39 $10.79 $10.79 $10.78 $11.56 $11.50 $11.79 $12.53 $12.41 $12.45 $12.37 $12.46 $8.82 $8.81 $8.68 $5.98 $6.25 $6.25
Net Debt/Share $2.07 $1.48 $1.11 $1.87 $1.34 $6.81 $1.08 $1.66 $7.17 $6.89 $6.81 $6.38 $6.11 $4.53 $-1.11 $-2.03 $-2.89 $-2.98 $-3.67 $-2.92 $-2.92
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.466
Altman Z-Prime snapshot only 3.621
Piotroski F-Score 5 6 7 7 5 4 6 5 7 5 6 5 7 6 4 5 4 5 6 8 8
Beneish M-Score -3.68 -2.98 -2.94 -2.78 -3.06 -2.81 -2.81 -2.75 -2.49 -2.53 -2.43 -2.55 -2.67 -2.74 -3.25 -3.16 -3.13 -3.36 -2.69 -2.51 -2.509
Ohlson O-Score snapshot only -8.303
ROIC (Greenblatt) snapshot only 23.58%
Net-Net WC snapshot only $-5.16
EVA snapshot only $234565388.47
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 38.91 45.72 40.85 44.50 35.74 35.94 35.28 34.96 47.97 35.75 41.95 36.04 38.14 59.12 37.32 40.36 40.52 51.90 64.37 64.03 64.034
Credit Grade snapshot only 8
Credit Trend snapshot only 23.679
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 60
Sector Credit Rank snapshot only 58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms